Expression of BMP7 in cervical cancer and inhibition of epithelial‑mesenchymal transition by BMP7 knockdown in HeLa cells

Int J Mol Med. 2020 May;45(5):1417-1424. doi: 10.3892/ijmm.2020.4519. Epub 2020 Feb 27.

Abstract

The aim of the present study was to investigate the expression of bone morphogenetic protein 7 (BMP7) in cervical cancer tissues, the effect of BMP7 on the proliferation, migration and epithelial‑mesenchymal transition (EMT) of cervical cancer HeLa cells and the possible mechanism involved. Immunohistochemistry was used to stain the cervical cancer tissues and benign or precancerous lesions. Lentivirus containing BMP7 knockdown was transfected in HeLa cells and western blotting was performed to analyze BMP7 expression. At the same time, the influence of BMP7 knockdown on the expression of phosphorylated (p)‑mothers against decapentaplegic homolog 1/5/9 and EMT‑related markers [epithelial‑cadherin, neural‑cadherin, Vimentin, Snail and Slug] was detected. Cell Counting Kit‑8 was used to detect cell proliferation. Transwell migration and invasion assays were performed to measure cell invasion and migration. The cell cycle was detected by flow cytometry. Compared with normal cervical epithelial and paracancerous cells, the positive rate of BMP7 expression in cervical cancer tissues was significantly increased. As compared with the control group, the expression of BMP7 was decreased in HeLa cells transfected with lentivirus. The knockdown of BMP7 in cervical cancer HeLa cells inhibited cell proliferation, migration and invasion, resulted in G1 cell cycle arrest and reversed the EMT process. In addition, the expression of p‑Smad1/5/9 was significantly decreased in HeLa cells with BMP7 knockdown. BMP7 is expected to be a possible target for the treatment of cervical cancer.

MeSH terms

  • Adult
  • Aged
  • Bone Morphogenetic Protein 7 / genetics*
  • Cadherins / genetics
  • Cell Cycle Checkpoints / genetics
  • Cell Line, Tumor
  • Cell Movement / genetics
  • Cell Proliferation / genetics
  • Cervix Uteri / pathology
  • Epithelial-Mesenchymal Transition / genetics*
  • Female
  • G1 Phase / genetics
  • Gene Expression Regulation, Neoplastic / genetics*
  • HeLa Cells
  • Humans
  • Middle Aged
  • Neoplasm Invasiveness / genetics
  • Transfection / methods
  • Uterine Cervical Neoplasms / genetics*
  • Vimentin / genetics

Substances

  • BMP7 protein, human
  • Bone Morphogenetic Protein 7
  • Cadherins
  • Vimentin